Combining paclitaxel and lapatinib as second-line treatment for patients with metastatic transitional cell carcinoma: a case series.

MLA

Culine, Stéphane, et al. “Combining Paclitaxel and Lapatinib as Second-Line Treatment for Patients with Metastatic Transitional Cell Carcinoma: A Case Series.” Anticancer Research, vol. 32, no. 9, Sept. 2012, pp. 3949–52. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=22993342&authtype=sso&custid=ns315887.

APA

Culine, S., Sellam, Z., Bouaita, L., Assaf, E., Delbaldo, C., Verlinde-Carvalho, M., & Pouessel, D. (2012). Combining paclitaxel and lapatinib as second-line treatment for patients with metastatic transitional cell carcinoma: a case series. Anticancer Research, 32(9), 3949–3952.

Chicago

Culine, Stéphane, Zineb Sellam, Linda Bouaita, Elias Assaf, Catherine Delbaldo, Muriel Verlinde-Carvalho, and Damien Pouessel. 2012. “Combining Paclitaxel and Lapatinib as Second-Line Treatment for Patients with Metastatic Transitional Cell Carcinoma: A Case Series.” Anticancer Research 32 (9): 3949–52. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=22993342&authtype=sso&custid=ns315887.